In Competition Law and Policy Debate, Raphaël De Coninck highlights the European Commission’s recent interest in assessing the impact of pharmaceutical mergers on innovation. The article discusses the Commission’s approach and argues in favor of developing a consistent framework for assessing the impact of mergers on innovations. To read more, click the link below.
ABA recognizes Economics Committee for innovative micro-economics video series
This award highlights the crucial role of innovation in enhancing member value within the ABA, showcasing the development of creative programs and content...